Skip to main content
OpenTrials
Completed

NCT Number: NCT03108573

Improved Detection of Multiple Sclerosis Plaques in Inversion Recovery by Optimization of Sequence Parameters

This study evaluates different optimized MRI sequences for the detection of brain lesions in patients with multiple sclerosis in comparison with the recommended FLAIR sequence

Completed

Looking for future studies?

Notify Me

Key information

About this study

MRI is a tool of choice for detecting demyelinating lesions in Multiple Sclerosis (MS) disease. On a consensual basis, the detection of those lesions in done on FLAIR (FLuid Attenuated Inversion Recovery) sequences, weighted T2 with cancelling of fluid signal, leading to a much better contrast between the lesion and the environment. The environment is displayed as a iso-signal for the surrounding healthy brain's white matter and as a hypo-signal for the fluids. Keys parameters indicative of the sequence's contrast are the echo time, the reversal time, and the repetition time, wich seems to be crucial to detect the lesions, according to relatively discordant results of publications using different technologies of FLAIR. Although 3D FLAIR sequences play an essential role for diagnosis and evaluation (evolution under treatment, prognosis) of demyelinating pathologies there is no consensus on parameters used on routine basis.

The aim of the trial is to discover the optimal combination of theses parameters so as to well detect the lesions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • relapsing remitting multiple sclerosis
  • MRI required

Exclusion criteria

  • MRI contraindication

Treatment and study plan

Primary outcomes

  1. Number of detectable lesions

    Time frame: baseline

    quantification of lesions on each sequence

Secondary outcomes

  1. localisation of lesions

    Time frame: baseline

    proportion of lesions localised in cerebellum or brainstem, on each sequence

Sponsors and collaborators

Lead sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Network

Registry information

Acronym: FLAIR-SEP

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Apr 11, 2017
Registry last updated
Apr 11, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.